Table-I.
Baseline characteristics & operative variables.
| Preoperative HbA1C | P value | ||||
|---|---|---|---|---|---|
| Low (n=13) | Median (n=45) | High (n=14) | |||
| Sex | Male/Female | 7/6 | 26/19 | 7/7 | 0,831* |
| Age | 62,85±7,84 | 62,4±10,27 | 66,21±10,21 | 0,302* | |
| LVEF | (<30) | 0 (0) | 2 (4,4) | 4 (28,6) | 0,910* |
| (30-50) | 10 (76,9) | 20 (44,4) | 3 (21,4) | ||
| (>50) | 3 (23,1) | 23 (51,1) | 7 (50) | ||
| Chronic renal failure | 1 (7,7) | 5 (11,1) | 1 (7,1) | 0,950 | |
| Hypertension | 10 (76,9) | 36 (80) | 11 (78,6) | 0,922 | |
| Previous cerebrovascular disease | 3 (23,1) | 1 (2,2) | 0 (0) | 0,011 | |
| Chronic pulmonary disease | 3 (23,1) | 3 (6,7) | 2 (14,3) | 0,499 | |
| Peripheral vascular disease | 1 (7,7) | 2 (4,4) | 0 (0) | 0,319 | |
| Previous Myocardial infaction | 1 (7,7) | 12 (26,7) | 4 (28,6) | 0,213 | |
| Left atrial dimension (cm) | 3,64±0,4 | 3,82±0,41 | 3,99±0,44 | 0,144 | |
| Number of anastomoses | 2,92±1,26 | 2,62±1,3 | 3,14±1,23 | 0,245 | |
| Number of arterial anastomoses | 1,15±0,55 | 1,27±0,5 | 1,5±0,52 | 0,066 | |
| Number of vein grafts | 2±0,82 | 1,66±0,55 | 1,7±0,95 | 0,462 | |
| Preoperative used of Beta- Blockers | 1 (7,7) | 15 (33,3) | 3 (21,4) | 0,451 | |
| Use of Levosimendan | 1 (7,7) | 3 (6,7) | 5 (35,7) | 0,025 | |
| Angiotensin converting inhibitors use | 4 (30,8) | 16 (35,6) | 8 (57,1) | 0,157 | |
| Use of Angiotensin receptor blockers | 2 (15,4) | 8 (17,8) | 1 (7,1) | 0,540 | |
| Use of Statins | 3 (23,1) | 14 (31,1) | 5 (35,7) | 0,482 | |
| Use of Oral antidiabetics | 11 (84,6) | 24 (53,3) | 10 (71,4) | 0,521 | |
| Use of Insulin | 1 (7,7) | 15 (33,3) | 2 (14,3) | 0,741 | |
| Use of Clopidogrel | 2 (15,4) | 8 (17,8) | 5 (35,7) | 0,189 | |
| Endartterectomy | 2 (15,4) | 4 (8,9) | 0 (0) | 0,150 | |
| Use of Intra-aortic balloon pump | 0 (0) | 0 (0) | 4 (28,6) | 0,001 | |
| Use of insulin during intensive care | 7 (53,8) | 18 (40) | 10 (76,9) | 0,243 | |
| Postoperative use of Dopamin | 4 (30,8) | 20 (44,4) | 9 (64,3) | 0,081* | |
| Postoperative use of Dobutamin | 2 (15,4) | 2 (4,4) | 7 (50) | 0,010* | |
| Postoperative use of Adrenalin | 1 (7,7) | 0 (0) | 4 (28,6) | 0,028* | |
| Postoperative use of Diltizem | 1 (7,7) | 8 (17,8) | 5 (35,7) | 0,066* | |
| Postoperative AF occurrence | 0 (0) | 4 (8,9) | 8 (57,1) | 0,000 | |
| Post-discharge AF | 0 (0) | 1 (2,2) | 4 (28,6) | 0,003 | |
| Mortality | 0 (0) | 0 (0) | 3 (21,4) | 0,005 | |
| Intubation time(hr) | 9,08±3,73 | 7,54±2,56 | 17,68±29,8 | 0,072 | |
| Chest tube drainage (ml) | 457,69±181,25 | 432,22±183,76 | 539,29±301,39 | 0,658 | |
| Intensive care unit stay time(hr) | 46,15±23,42 | 39,33±10,97 | 63,43±31,02 | 0,006 | |
| Mean time to AF occurrence (day) | - | 1,5±1 | 1,38±0,74 | 0,911 | |
Data are number (percent), mean ± standard deviation, or median [25th–75th percentile]. Low 4.5-5.4%; Median, 5.5-8%; High, >8.%.